These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2518222)

  • 1. Effect of antiulcer agents on the physicochemical properties of gastric mucus.
    Slomiany BL; Murty VL; Piotrowski J; Slomiany A
    Symp Soc Exp Biol; 1989; 43():179-91. PubMed ID: 2518222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mucus in gastric mucosal protection.
    Slomiany BL; Slomiany A
    J Physiol Pharmacol; 1991 Jun; 42(2):147-61. PubMed ID: 1782415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro.
    Slomiany BL; Nishikawa H; Bilski J; Slomiany A
    Am J Gastroenterol; 1990 Apr; 85(4):390-3. PubMed ID: 2109526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the physicochemical qualities of gastric mucus by sofalcone.
    Piotrowski J; Yamaki K; Tamura S; Slomiany A; Slomiany BL
    J Physiol Pharmacol; 1991 Sep; 42(3):293-304. PubMed ID: 1793890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sofalcone administration on the physicochemical properties of gastric mucus.
    Slomiany BL; Tamura S; Piotrowski J; Slomiany A
    J Clin Gastroenterol; 1992; 14 Suppl 1():S88-93. PubMed ID: 1378469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mucus barrier. Its role in gastroduodenal mucosal protection.
    Allen A; Leonard AJ; Sellers LA
    J Clin Gastroenterol; 1988; 10 Suppl 1():S93-8. PubMed ID: 3053885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
    Ishihara K; Ichikawa T; Komuro Y; Ohara S; Hotta K
    Arzneimittelforschung; 1994 Jul; 44(7):827-30. PubMed ID: 7945516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebrotidine--a new H2-receptor antagonist with mucosal strengthening activity.
    Piotrowski J; Yamaki K; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 Mar; 26(4):659-67. PubMed ID: 1351724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucus and pepsin role in gastric damage prevention by H2-receptor antagonists and antiulcer drugs.
    Impicciatore M; Morini G; Chiavarini M; Plazzi PV; Agosti A; Soldani G
    Acta Physiol Hung; 1984; 64(3-4):253-7. PubMed ID: 6152367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mucus in mucosal protection through ethanol and pepsin damage models.
    Matúz J
    Acta Physiol Hung; 1992; 80(1-4):189-94. PubMed ID: 1345186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
    Fromm D
    Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
    Copeman M; Matuz J; Leonard AJ; Pearson JP; Dettmar PW; Allen A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S55-9. PubMed ID: 7881020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.
    Piotrowski J
    J Physiol Pharmacol; 1998 Mar; 49(1):3-24. PubMed ID: 9594407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
    Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration.
    Piotrowski J; Bilski J; Nishikawa H; Slomiany A; Slomiany BL
    Eur J Pharmacol; 1990 Aug; 184(1):55-63. PubMed ID: 2209715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healing.
    Slomiany BL; Piotrowski J; Majka J; Czajkowski A; Slomiany A; Gabryelewicz A
    Gen Pharmacol; 1995 Sep; 26(5):1039-44. PubMed ID: 7557247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of the enhancement of the protective qualities of gastric mucus by sucralfate.
    Slomiany BL; Piotrowski J; Okazaki K; Grzelinska E; Slomiany A
    Digestion; 1989; 44(4):222-31. PubMed ID: 2483693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.